OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Industry perspective on the nonclinical safety assessment of heterobifunctional degraders
Michelle Hemkens, Katie Stamp, Lise I. Loberg, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 8, pp. 103643-103643
Closed Access | Times Cited: 8
Michelle Hemkens, Katie Stamp, Lise I. Loberg, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 8, pp. 103643-103643
Closed Access | Times Cited: 8
Showing 8 citing articles:
Overview of epigenetic degraders based on PROTAC, molecular glue, and hydrophobic tagging technologies
Xiaopeng Peng, Zhihao Hu, Limei Zeng, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 2, pp. 533-578
Open Access | Times Cited: 25
Xiaopeng Peng, Zhihao Hu, Limei Zeng, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 2, pp. 533-578
Open Access | Times Cited: 25
Nonclinical teratogenicity safety assessment of CRBN-engaging targeted protein degraders: Points to consider
Lise I. Loberg, William R Proctor, Andrew D. Burdick, et al.
Regulatory Toxicology and Pharmacology (2025), pp. 105793-105793
Closed Access
Lise I. Loberg, William R Proctor, Andrew D. Burdick, et al.
Regulatory Toxicology and Pharmacology (2025), pp. 105793-105793
Closed Access
Optimization of Potent Ligands for the E3 Ligase DCAF15 and Evaluation of Their Use in Heterobifunctional Degraders
Simon C. C. Lucas, Afshan Ahmed, Saba Ashraf, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 7, pp. 5538-5566
Closed Access | Times Cited: 3
Simon C. C. Lucas, Afshan Ahmed, Saba Ashraf, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 7, pp. 5538-5566
Closed Access | Times Cited: 3
Targeting EGFR with molecular degraders as a promising strategy to overcome resistance to EGFR inhibitors
Qiangfeng Wang, Yumeng Zhu, Junping Pei
Future Medicinal Chemistry (2024) Vol. 16, Iss. 18, pp. 1923-1944
Closed Access | Times Cited: 1
Qiangfeng Wang, Yumeng Zhu, Junping Pei
Future Medicinal Chemistry (2024) Vol. 16, Iss. 18, pp. 1923-1944
Closed Access | Times Cited: 1
Targeted degrader technologies as prospective SARS-CoV-2 therapies
Rabia Khurshid, Joseph M. Schulz, Jiaming Hu, et al.
Drug Discovery Today (2023) Vol. 29, Iss. 1, pp. 103847-103847
Closed Access | Times Cited: 3
Rabia Khurshid, Joseph M. Schulz, Jiaming Hu, et al.
Drug Discovery Today (2023) Vol. 29, Iss. 1, pp. 103847-103847
Closed Access | Times Cited: 3
Session 5: Protein Degraders
Kiran Palyada, Renee Hukkanen, Stephanie Leuenroth-Quinn, et al.
Toxicologic Pathology (2024)
Closed Access
Kiran Palyada, Renee Hukkanen, Stephanie Leuenroth-Quinn, et al.
Toxicologic Pathology (2024)
Closed Access
